- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
March 16, 2023Second Circuit Affirms Record $5.6 Billion Recovery in Antitrust Case
March 10, 2023Robins Kaplan Announces $28 Million Settlement in Case Against For-Profit College’s Directors & Officers
March 9, 2023Robins Kaplan LLP Launches New Professional Development Program
March 19-22, 2023PLRB 2023 Claims Conference
March 29-30, 2023ACI Managed Care Disputes and Litigation
April 3, 2023Conference of Tribal Lending Commissioners
March 13, 2023The Antitrust Case that Could Reshape Professional Golf
February 22, 2023A World Without Noncompetes: Protecting Confidential Information and Trade Secrets
February 7, 2023When Monkey Business Slips Into Trademark Infringement
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Medical Malpractice Case Report: $1.7 Million Settlement for Negligent Failure to Timely Diagnose and Treat Oral Cancer
Reached a $1.7 million medical malpractice settlement in a case involving a negligent failure to timely diagnose and treat oral cancer in young woman. Read the following Minnesota Association for Justice (MAJ) Minnesota Case Report, Volume 28, Number 5, October 2009:
(Excerpts taken with permission from Minnesota Association for Justice (MAJ) “Minnesota Case Reports”)
This case of dental negligence arose out of the failure to timely diagnose and treat oral cancer in a woman who was in her 30's at the time of diagnosis. Over a four year period of time, she had been referred, on multiple occasions, to an oral surgeon for evaluation of a lesion on her tongue. Following the findings and final evaluation of the patient, the oral surgeon referred this patient to an oral medicine specialist who evaluated the lesion and provided treatment over the course of the next seven months. In the seventh month, a biopsy of the tongue lesion was performed that resulted in the diagnosis of squamous cell carcinoma of the left lateral tongue. After extensive staging an devaluation, the patient was diagnosed with advanced Stage III, T2, N1, MO Grade 111 squamous cell carcinoma of the tongue. Because of the metastatic disease, the patient required extensive head and neck surgery as well as radiation and chemotherapy, resulting in numerous side effects and complications. Patient's treating physicians as well as plaintiff's oncologist opined that the delay in diagnosis resulted in a five-year survival rate of 30 - 40% and that, had the diagnosis been made on a timely basis, the patient's chances for five-year survival would have been greater than 70%.
Defendant's alleged that patient was negligent in failing to return for follow-up evaluations. Further, defendants' experts alleged that defendant property evaluated patient. Additionally, defendants' experts as well as plaintiff's treating physician opined that it is impossible to determine at what point in time plaintiff's oral lesion became cancerous and further, whether earlier diagnosis would have been possible prior to metastasis of the disease. Plaintiff's treating physician agreed that it would be speculative to comment as to whether patient had Stage 1 or Stage II cancer at any specific period of time and further, what the specific growth rate of her tumor was or how long the tumor had been present.
Settlement: $1.7 million for all defendants
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.